| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.GDE.2018.01.001 |
| P8608 | Fatcat ID | release_eue2glr3lne5pn67bqwhrxd77m |
| P932 | PMC publication ID | 5986298 |
| P698 | PubMed publication ID | 29429825 |
| P50 | author | Muller Fabbri | Q66414308 |
| P2093 | author name string | Francesca Fanini | |
| Ivan Vannini | |||
| P2860 | cites work | Serum microRNAs are promising novel biomarkers | Q21144238 |
| Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells | Q21245767 | ||
| Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis | Q24307717 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| A microRNA code for prostate cancer metastasis | Q27310006 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response | Q29615493 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. | Q34683987 | ||
| miR-15b/16-2 deletion promotes B-cell malignancies | Q36078983 | ||
| Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy | Q36294761 | ||
| Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease | Q36355607 | ||
| DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer | Q36427777 | ||
| Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles | Q36751657 | ||
| The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism? | Q37339419 | ||
| Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization | Q37360069 | ||
| Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas | Q37728669 | ||
| Discovery of small molecule cancer drugs: successes, challenges and opportunities | Q37996113 | ||
| Ectosomes and exosomes: shedding the confusion between extracellular vesicles | Q38356431 | ||
| Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor. | Q38435063 | ||
| Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK. | Q38718324 | ||
| MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells | Q38952779 | ||
| miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. | Q39612245 | ||
| Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. | Q40144403 | ||
| Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers | Q45862369 | ||
| let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery | Q47134084 | ||
| MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. | Q53266940 | ||
| P921 | main subject | microRNA | Q310899 |
| P577 | publication date | 2018-02-08 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | Emerging roles of microRNAs in cancer |
| Q57795870 | A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis |
| Q90384025 | Adipocytes and microRNAs Crosstalk: A Key Tile in the Mosaic of Breast Cancer Microenvironment |
| Q90347551 | An Overview of Vasculogenic Mimicry in Breast Cancer |
| Q92152017 | Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy |
| Q64238120 | DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma |
| Q92447657 | Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma |
| Q57476477 | Effect of exosomal miRNA on cancer biology and clinical applications |
| Q57185092 | Epigenetic upregulation of miR-126 induced by heat stress contributes to apoptosis of rat cardiomyocytes by promoting Tomm40 transcription |
| Q60960583 | Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study |
| Q89992237 | Genipin inhibits the scleral expression of miR-29 and MMP2 and promotes COL1A1 expression in myopic eyes of guinea pigs |
| Q64911477 | Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. |
| Q64933510 | Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis. |
| Q58765854 | MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting |
| Q89481554 | MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol |
| Q92617996 | MiR-92a promotes the invasion and migration of colorectal cancer by targeting RECK |
| Q64896036 | MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading. |
| Q64076404 | MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion |
| Q64898549 | MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2. |
| Q92648755 | MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1 |
| Q57814100 | MicroRNAs as Biomarkers of B-cell Lymphoma |
| Q60928850 | MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage |
| Q93090382 | MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4 |
| Q91671037 | Non-Coding RNAs in Retinoblastoma |
| Q64891567 | Pancreatic β-cell function is inhibited by miR-3666 in type 2 diabetes mellitus by targeting adiponectin. |
| Q64105768 | Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2 |
| Q90149278 | Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies |
| Q64095238 | Single Nucleotide Polymorphisms in Contribute to Protection Against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations |
| Q91715704 | The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer |
| Q60960314 | The miRNA Expression Profile of Experimental Autoimmune Encephalomyelitis Reveals Novel Potential Disease Biomarkers |
| Q98289714 | Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC |
| Q58797073 | Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1 |
| Q64262461 | miR-1915-3p inhibits Bcl-2 expression in the development of gastric cancer |
| Q59793155 | miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) |
Search more.